Bronchitis, Bronchiolitis und Lungenemphysem

  • Adrian Gillissen
  • Stefan Zielen


  1. American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152:S77–S120Google Scholar
  2. Anthonisen NR, Connett JE, Kiley JP et al. (1994) Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Heath Study. JAMA 272:1539–1541CrossRefGoogle Scholar
  3. Anthonisen NR, Manfreda J, Warren CPW (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106:196–204PubMedGoogle Scholar
  4. Barnes P, Godfrey S (1997) Chronic obstructive pulmonary disease. Martin Dunitz, LondonGoogle Scholar
  5. Barnes PJ (2000) Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:342–344PubMedGoogle Scholar
  6. British Thoracic Society (1997) Guidelines for the management of chronic obstructive pulmonary disease. Thorax 52:S1–S28Google Scholar
  7. Calverley PMA (2000) Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:341–344PubMedGoogle Scholar
  8. Canadian Thoracic Society Workshop Group (1992) Guidelines for the assessment and management of chronic obstructive pulmonary disease. Can Med Assoc J 147:420–428Google Scholar
  9. Davies L, Angus RM, Calverley PMA (1999) Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 354:456–460PubMedGoogle Scholar
  10. Demeester J, Smits JMA, Persijn GG, Haverich A (1999) Lung transplant waiting list: differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 18:563–571Google Scholar
  11. Deutsche Gesellschaft für Pneumologie (1993) Empfehlungen zur Sauerstoff-Langzeit-Therapie bei schwerer chronischer Hyoxämie. Pneumologie 47:2–4Google Scholar
  12. Fabbri LM, Caramori G, Beghe B et al. (1998) Chronic obstructive pulmonary disease international guidelines. Curr Opin Pulm Med 4:76–84PubMedGoogle Scholar
  13. Fletcher C, Peto R (1977) The natural history of chronic airway obstruction. Br Med J 1:1645–1648PubMedGoogle Scholar
  14. Gehring S, Rabenau H, Schneider W, Zielen S (1996) Adenovirusinfektionen als Ursache schwerer pulmonaler Erkrankungen im Kindesalter. Pädiatr Grenzgeb 34:325–330Google Scholar
  15. Gillissen A, Buhl R, Kardos P et al. (2000) Inhalierbare Kortikosteroide in der Langzeittherapie der COPD. Stellungnahme eines Expertengremiums. Pneumologie 54: 256–262PubMedGoogle Scholar
  16. Gillissen A, Tasci S, Ewig S, Schäfer H, Zielen S (2001) Sinn und Unsinn von Antitussiva. Internist 42:134–142CrossRefPubMedGoogle Scholar
  17. Irwing RS, Boulet L-P, Cloutier MM et al. (1998) Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American Chest Physicians. Chest 114:133s–181sGoogle Scholar
  18. Jorenby DE, Leischow SJ, Niedes MA et al. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340: 685–691CrossRefPubMedGoogle Scholar
  19. Kardos P, Gebhardt T, Decot E (1995) Chronisch persistierender Husten (CPH): Therapie. Pneumologie 49:47–54PubMedGoogle Scholar
  20. Keenan SP, Brake D (1998) An evidence-based approach to noninvasive ventilation in acute respiratory failure. Crit Care Clin 14:359–372CrossRefPubMedGoogle Scholar
  21. Medical Research Council Working Party (1981) Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1:681–686Google Scholar
  22. Niewoehner DE, Erbland ML, Deupree RH et al. (1999) Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 340:1941–1947CrossRefPubMedGoogle Scholar
  23. Nocturnal Oxygen Therapy Trial Group (1980) Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 93:391–398Google Scholar
  24. Pauwels RA, Lofdahl C-G, Laitinen LA et al. (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 340:1948–1953CrossRefPubMedGoogle Scholar
  25. Peter G, Lepow M, McCracken GHE (1991) Ribavirin therapy of respiratory syncytial virus. Report of the committee of infectious diseases. Am Acad Pediatr 22:581–587Google Scholar
  26. Petro W, Wettengel R, Worth H (1995) Empfehlungen zum strukturierten Patiententraining bei obstruktiven Atemwegserkrankungen. Pneumologie 49:455–460Google Scholar
  27. Petty TL, Weinmann GG (1997) Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. JAMA 277:246–253CrossRefPubMedGoogle Scholar
  28. Schulz C, Riedel M, Gillissen A, Emslander HP (1998) Präoperative Identifizierung des pulmonalen Risikopatienten vor Lungenresektion. Atemw Lungenkrkh 24:205–214Google Scholar
  29. Tarpy SP, Celli BR (1995) Long-term oxygen therapy. N Engl J Med 333:710–714CrossRefPubMedGoogle Scholar
  30. Vestbo J, Sørensen T, Langer P, Brix A, Torre P, Viskum K (1999) Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 355:1819–1823Google Scholar
  31. Wettengel R, Berdel D, Cegla U et al. (1994) Empfehlungen der Deutschen Atemwegsliga zum Asthma Management bei Erwachsenen und bei Kindern. Med Klinik 89: 57–67Google Scholar
  32. Wettengel R, Böhning W, Cegla U et al. (1995) Empfehlungen der Deutschen Atemwegsliga zur Behandlung von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem. Med Klinik 90: 3–7Google Scholar
  33. Witt C, Schmidt W (2000) Risikofaktoren der COPD. In: Gillissen A (Hrsg) Die chronisch obstruktive Lungenerkrankung. Uni-Med Verlag, Bremen, S 32–43Google Scholar
  34. World Health Organization (1961) WHO report of an expert committee: Definition and diagnosis of pulmonary disease with special reference to chronic bronchitis and emphysema. WHO Techn Rep Ser 213:14–19Google Scholar
  35. Worth H, Adam D, Handrick W et al. (1997) Prophylaxe und Therapie von bronchiale Infektionen. Med Klinik 12: 699–704Google Scholar

Copyright information

© Springer-Verlag Heidelberg 2005

Authors and Affiliations

  • Adrian Gillissen
  • Stefan Zielen

There are no affiliations available

Personalised recommendations